hoe 33342 and Kidney Neoplasms

hoe 33342 has been researched along with Kidney Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addla, SK; Brown, MD; Clarke, NW; Hart, CA; Ramani, VA1
Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J1

Other Studies

2 other study(ies) available for hoe 33342 and Kidney Neoplasms

ArticleYear
Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:3

    Topics: Benzimidazoles; Carcinoma, Renal Cell; Cell Proliferation; Collagen; Drug Combinations; Epithelial Cells; Fluorescent Dyes; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Laminin; Proteoglycans

2008
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
    Cancer research, 2002, Jul-15, Volume: 62, Issue:14

    Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow

2002